![William Charles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Charles
Director/Miembro de la Junta en SapVax LLC .
Perfil
William Charles is currently the Executive Director of Investment at Auckland UniServices Ltd.
He is also a Director at SapVax LLC.
Previously, he held positions as a Director at Pathway Therapeutics Ltd.
and Objective Acuity Ltd.
He also worked as a Principal at Celltech Group Plc, Novartis AG, GlaxoSmithKline Pharmaceuticals SA (Belgium), and Roche AB.
Cargos activos de William Charles
Empresas | Cargo | Inicio |
---|---|---|
Auckland UniServices Ltd.
![]() Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Inversor de Capital Privado | - |
SapVax LLC
![]() SapVax LLC Pharmaceuticals: MajorHealth Technology SapVax LLC develops a platform for generating peptide-based, self-adjuvanting cancer vaccines. Its platform is based on a flexible synthetic method for linking tumor antigens with an adjuvant, which enables the generation of vaccines targeting virtually any peptide tumor antigen. The company was founded by Rod Dunbar and Margaret Brimble in 2016 and is headquartered in Cleveland, OH. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de William Charles.
Empresas | Cargo | Fin |
---|---|---|
Objective Acuity Ltd.
![]() Objective Acuity Ltd. Electronic Equipment/InstrumentsElectronic Technology Objective Acuity Ltd. develops vision testing equipment to detect visual function. The company was founded by Benjamin Thompson, Jason Turuwhenua and Mehrdad Sangi and is headquartered in Auckland, New Zealand. | Director/Miembro de la Junta | 01/10/2018 |
Pathway Therapeutics Ltd.
![]() Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Pathway Therapeutics Ltd. developed drugs for the treatment of cancer. The company was founded in 2007 and was headquartered in Auckland, New Zealand. | Director/Miembro de la Junta | - |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - |
Roche AB
![]() Roche AB Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche AB is a biotechnology company founded in 1896. The company is based in Solna, Sweden and creates innovative treatments to help millions of patients worldwide. Roche actively seeks partnerships with healthcare providers, academia, patient associations, organizations, external companies, and startups to identify needs that form the basis for collaborations. Roche is one of the world's largest research-based biotechnology companies, focusing on advancing science to improve people's lives. The Swedish company develops both drugs and diagnostics and has great respect for the multiple perspectives required to create tomorrow's healthcare. | Corporate Officer/Principal | - |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
![]() GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NOVARTIS AG | Health Technology |
Empresas privadas | 7 |
---|---|
Auckland UniServices Ltd.
![]() Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Finance |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
![]() GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
Roche AB
![]() Roche AB Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche AB is a biotechnology company founded in 1896. The company is based in Solna, Sweden and creates innovative treatments to help millions of patients worldwide. Roche actively seeks partnerships with healthcare providers, academia, patient associations, organizations, external companies, and startups to identify needs that form the basis for collaborations. Roche is one of the world's largest research-based biotechnology companies, focusing on advancing science to improve people's lives. The Swedish company develops both drugs and diagnostics and has great respect for the multiple perspectives required to create tomorrow's healthcare. | Health Technology |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Pathway Therapeutics Ltd.
![]() Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Pathway Therapeutics Ltd. developed drugs for the treatment of cancer. The company was founded in 2007 and was headquartered in Auckland, New Zealand. | Health Technology |
Objective Acuity Ltd.
![]() Objective Acuity Ltd. Electronic Equipment/InstrumentsElectronic Technology Objective Acuity Ltd. develops vision testing equipment to detect visual function. The company was founded by Benjamin Thompson, Jason Turuwhenua and Mehrdad Sangi and is headquartered in Auckland, New Zealand. | Electronic Technology |
SapVax LLC
![]() SapVax LLC Pharmaceuticals: MajorHealth Technology SapVax LLC develops a platform for generating peptide-based, self-adjuvanting cancer vaccines. Its platform is based on a flexible synthetic method for linking tumor antigens with an adjuvant, which enables the generation of vaccines targeting virtually any peptide tumor antigen. The company was founded by Rod Dunbar and Margaret Brimble in 2016 and is headquartered in Cleveland, OH. | Health Technology |
- Bolsa de valores
- Insiders
- William Charles